Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
Public ClinicalTrials.gov record NCT06543914. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A ProspeCtive ObseRvatioNal Study of Atogepant Effectiveness in Routine Clinical Practice
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will evaluate the effectiveness of atogepant in treating adult participants with migraine in a real-world setting. Atogepant is an approved drug for preventive treatment of migraine in adults. Approximately 1000 adult participants who are prescribed atogepant by their doctors will be enrolled in this study across the world. Participants will receive atogepant oral tablets as prescribed per standard clinical practice and will be followed for 2 years. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.
Study identification
- NCT ID
- NCT06543914
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 1,314 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 25, 2024
- Primary completion
- Jan 31, 2029
- Completion
- Jan 31, 2029
- Last update posted
- May 31, 2026
2024 – 2029
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Neurology and Neurodiagnostics of Alabama /ID# 267614 | Hoover | Alabama | 35244 | — |
| Rehabilitation & Neurological Services /ID# 267612 | Huntsville | Alabama | 35805-4046 | — |
| Barrow Neurological Institute - Dignity Health St. Joseph's Hosp and Medical Ctr /ID# 267610 | Phoenix | Arizona | 85013 | — |
| Kenneth Martinez MD, A Medical Corp /ID# 267834 | Aliso Viejo | California | 92656 | — |
| BNL Health - Los Angeles Headache Center /ID# 267570 | Los Angeles | California | 90067-2001 | — |
| Alcanza Clinical Research, LLC /ID# 267838 | Lake Mary | Florida | 32746-2118 | — |
| Norton Cancer Institute - St. Matthews /ID# 267605 | Louisville | Kentucky | 40207 | — |
| Dent Neurologic Institute - Amherst /ID# 267606 | Amherst | New York | 14226 | — |
| Northwell Health - Great Neck /ID# 280705 | Great Neck | New York | 11021 | — |
| Northwell Health /ID# 267596 | New York | New York | 10022-1304 | — |
| Thomas Jefferson University Hospital /ID# 267572 | Philadelphia | Pennsylvania | 19107 | — |
| Inova Health Care System /ID# 267615 | Falls Church | Virginia | 22042 | — |
| Neuroscience Group /ID# 267571 | Neenah | Wisconsin | 54956-1993 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 99 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06543914, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 31, 2026 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06543914 live on ClinicalTrials.gov.